Skip to main content
ScholarsBetaWeill Cornell Medicine

Publications

25 publications

Funding

7 grants

Active

5 grants
  • Co-I
    Elucidating single cell changes in neurogenic brain regions during HIV and cannabinoid exposure
    National Institute on Drug Abuse · 2023–2028
    U01DA058527-04
  • Co-I
    Receptor for hyaluronan-mediated motility isoform B (RHAMM B) in Pancreatic Cancer Metastasis
    National Cancer Institute · 2022–2027
    R01CA266758-01A1
  • KP
    HOPE - HIV Obstruction by Programmed Epigenetics
    National Institute of Allergy and Infectious Diseases · 2021–2027 · via University of California, San Francisco
    UM1AI164559-05
  • Co-I
    REACH: Research Enterprise to Advance a Cure for HIV
    National Institute of Allergy and Infectious Diseases · 2021–2027· 2 renewals
    UM1AI164565-06
  • Co-I
    Integrative Single Cell Isoform And Chromatin Accessibility Mapping Of Chronic Opioid Exposure In Cognitive Brain Areas In HIV
    National Institute on Drug Abuse · 2021–2027
    U01DA053625-05
Completed grants (2)
  • Co-I
    Regulatory Crosstalk Between Human Endogenous Retroviruses, HIV, and EBV, in Lymphoma
    National Cancer Institute · 2021–2024
    R01CA260691-01
  • KP
    BELIEVE: Bench to Bed Enhanced Lymphocyte Infusions to Engineer Viral Eradication
    National Institute of Allergy and Infectious Diseases · 2018–2023
    UM1AI126617-03

News mentions

1 mentionView all WCM news ↗
  • Grant Funds Study of Cannabis Effects on HIV-Infected Brain Tissue
    May 22, 2023

    Weill Cornell Medicine has been awarded a five-year, $11.6 million grant from the National Institute on Drug Abuse (NIDA) of the National Institutes of Health to study the effects cannabis, including marijuana and compounds derived from it, may have on the brains of those living with HIV.